TFX Stock Analysis: Buy, Sell, or Hold?
TFX - Teleflex Incorporated
$133.99
4.24 (3.27%)
▲
5d:
+4.85%
30d:
+6.99%
90d:
+13.15%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 30, 2026
25d
Get Alerted When TFX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TFX shows positive signals but monitor for confirmation. Market pricing in 8.0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: TFX shows positive signals but monitor for confirmation. Market pricing in 8.0% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$207.41
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$128.79
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TFX is currently trading at $133.99, which is considered extended relative to its 30-day fair value range of $125.93 to $131.92. From a valuation perspective, the stock is trading at a premium (Forward PE: 12.7) compared to its historical average (10.1). At these levels, the market is pricing in 8.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TFX is in a strong uptrend. The price is approaching resistance at $134.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: TFX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TFX is in a strong uptrend. The price is approaching resistance at $134.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: TFX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$125.93 -
$131.92
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
68.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- NEUTRAL: Near Wall St target ($145.89)
- NEUTRAL: Trading at premium valuation - market expects 8.0% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$125.93 -
$131.92
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$7.06
(5.3%)
Support & Resistance Levels
Support Level
$120.86
Resistance Level
$134.53
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.71
Wall Street Target
$145.89
(+8.9%)
Revenue Growth (YoY)
32.3%
Earnings Growth (YoY)
64.1%
Profit Margin
-47.4%
Valuation Premium vs History
+8.0% premium
PE vs Historical
12.7 vs 10.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.0%
(market-implied from PE analysis)
1-Year Target
$144.71
(+8%)
2-Year Target
$156.29
(+17%)
3-Year Target
$168.79
(+26%)
3-Yr Target (if PE normalizes)
(PE: 13→10)
PE COMPRESSION
$134.17
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 57.3%)
$775.17
(+479%)
Base:
(SPY PE: 12.7, Growth: 57.3%)
$452.22
(+238%)
Bear:
(PE: 10.1, Growth: 57.3%)
$359.47
(+168%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Forward PE: 19.65 | Forward EPS (Implied): $6.82
Bull Case
$161.79
(+21%)
Analyst growth 15.0%, PE expands to 20.6
Base Case
$133.99
(0%)
Market implied 0.0%, PE stable at 19.7
Bear Case
$102.50
(-24%)
Severe decline -15.0%, PE contracts to 17.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 10:14 PM ET
Data refreshes hourly during market hours. Next update: 11:14 PM
Data refreshes hourly during market hours. Next update: 11:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TFX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
Advanced TFX Option Strategies
Professional options setups generated by AI based on today's TFX price and gamma walls.
